Private Prescription Comparison: Mechanisms & Practical Differences
What Is Better Mounjaro or Wegovy: Private vs NHS Route
Understanding what is better mounjaro or wegovy requires examining both the medications themselves and how you access them. The NHS route typically involves GP referral to specialist weight management services, with waiting times often exceeding 6 months and strict eligibility criteria. Private prescription through EverydayMeds eliminates these barriers entirely, providing the same genuine treatments with professional oversight but without delays. Both Wegovy and Mounjaro are available through our GPhC-registered pharmacy, allowing your prescriber to recommend the most suitable option based on your individual circumstances.
The private route offers transparent pricing and immediate access to these prescription-only medicines. Rather than uncertainty about NHS availability or postcode lottery variations, you receive Reliable Supply with temperature-controlled delivery. Your clinical assessment takes just 3 minutes, with prescriber review typically completed within 24 hours, meaning you could begin treatment this week rather than waiting months through traditional NHS channels.
Wegovy vs Mounjaro Pricing: Private Prescription UK Costs
When comparing what is better mounjaro or wegovy from a cost perspective, Wegovy pricing through EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg) to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, whilst returning patients use DOSE25. Our bundle options provide convenience for longer-term treatment, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99.
Unlike NHS prescription charges of £9.90 per item, private prescription provides complete treatment transparency with no hidden costs or sudden availability issues. The investment in private treatment often proves cost-effective when considering the immediate access, professional support, and Reliable Supply chain. Both Wegovy and Mounjaro require similar private prescription fees, making the choice between them based on clinical factors rather than cost differential.
Clinical Evidence: What Is Better Mounjaro or Wegovy Research
Rather than declaring what is better mounjaro or wegovy definitively, clinical evidence shows both treatments demonstrate significant efficacy in their respective trials. The STEP trials for Wegovy showed patients achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle changes, as documented by Wilding et al., NEJM, 2021. Mounjaro's SURMOUNT trials demonstrated similar impressive results with its dual GIP/GLP-1 mechanism.
However, these trials used different methodologies, patient populations, and endpoints, making direct percentage comparisons inappropriate. What matters more is that both treatments represent clinically proven options for weight management when prescribed appropriately. Your EverydayMeds prescriber can review your medical history to determine which mechanism may suit your individual circumstances best.
Wegovy Mechanism: How This GLP-1 Treatment Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormones. When injected once weekly, it works on brain appetite centres to reduce hunger signals and promote earlier satiety after smaller meals. This mechanism may help reduce food cravings and support portion control naturally, rather than through stimulant-based appetite suppression. The treatment works alongside your body's existing regulatory systems, which is why it must be combined with a reduced-calorie diet and increased physical activity. Clinical studies suggest this approach provides sustainable weight management support when used consistently over time.
Ordering Process: From Assessment to Delivery
The EverydayMeds ordering process for either Wegovy or Mounjaro begins with a comprehensive 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your information within standard 3 working days, or 24 hours with express service, ensuring safe and appropriate prescribing of these prescription-only medicines. Once approved, your treatment ships via next-day delivery using specialist cold-chain transport to maintain the 2-8°C temperature requirement. Each package includes complete dosing instructions, injection guidance, and ongoing support contact details. This streamlined process eliminates the complex referral pathways and waiting lists associated with NHS access whilst maintaining full clinical oversight.
Storage and Practical Considerations
When evaluating what is better mounjaro or wegovy for practical daily use, storage requirements present a key difference. Wegovy pens maintain potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. This advantage makes Wegovy particularly suitable for frequent travellers or those with unreliable refrigeration access. Both treatments use easy-to-operate pre-filled FlexTouch pens requiring once-weekly injection, typically in the thigh, abdomen, or upper arm. The dose escalation schedule progresses gradually over 16 weeks to reach maintenance levels, allowing your body to adjust and minimising potential side effects. Proper rotation of injection sites and consistent weekly timing optimises treatment effectiveness for both medications.
Private Prescription Advantages: What Is Better Mounjaro or Wegovy Access
Private prescription access transforms the question of what is better mounjaro or wegovy from theoretical comparison into practical choice. NHS patients often face rigid protocols, limited dose flexibility, and potential treatment interruptions due to supply chain issues. Private patients access both options simultaneously, allowing clinical adjustment based on individual response and tolerance. Your prescriber can modify dosing schedules, switch between treatments if needed, or provide additional support without referral delays.
The private route also ensures consistent supply regardless of NHS availability fluctuations or NICE guideline changes. Both treatments remain accessible through EverydayMeds even when NHS services face capacity constraints or regional variations in commissioning decisions. This reliability proves particularly valuable for patients who achieve stable weight management and require long-term maintenance therapy without interruption.
Making Your Choice: Professional Guidance and Next Steps
Ultimately, determining what is better mounjaro or wegovy depends on your individual medical profile, lifestyle factors, and treatment preferences. Both treatments are available from EverydayMeds, and your prescriber can help determine which option aligns best with your circumstances. The dual mechanism of Mounjaro may suit some patients, whilst others prefer Wegovy's established GLP-1 approach and superior storage flexibility. New customers can begin with discount code FIRST40, making either treatment accessible from £79.99 for Wegovy's starter dose. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and begin your weight management journey with professional support and Reliable Supply. Our clinical team maintains GPhC registration #9012878, ensuring full regulatory compliance and patient safety throughout your treatment experience.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
